CODX Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Co Diagnostics
CODX Stock  USD 2.83  0.09  3.08%   
Co Diagnostics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Co Diagnostics' valuation are provided below:
Gross Profit
172.8 K
Market Capitalization
4.9 M
Enterprise Value Revenue
5.4117
Revenue
507.9 K
Earnings Share
(29.40)
We have found one hundred twenty available fundamental measures for Co Diagnostics, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to validate all of Co Diagnostics latest market performance against the performance between 2010 and 2026 to make sure the company can sustain itself in the future. Market Cap is likely to drop to about 57.4 M in 2026. Enterprise Value is likely to drop to about 46.2 M in 2026

Co Diagnostics Total Revenue

4.28 Million

Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 18 M or Selling General Administrative of 19.5 M, as well as many indicators such as Price To Sales Ratio of 6.35, Dividend Yield of 0.0 or PTB Ratio of 0.46. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Build AI portfolio with CODX Stock
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Co Diagnostics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets52.4 M73.6 M38.3 M
Slightly volatile
Other Current Liabilities2.4 M3.6 M1.8 M
Slightly volatile
Total Current Liabilities4.2 M8.4 M3.3 M
Slightly volatile
Property Plant And Equipment Net5.9 M5.6 M1.7 M
Slightly volatile
Accounts Payable4 M3.8 M919.9 K
Slightly volatile
Cash3.2 M3.4 M11 M
Slightly volatile
Non Current Assets Total38.3 M36.5 M12.9 M
Slightly volatile
Cash And Short Term Investments31.3 M34.2 M22.3 M
Slightly volatile
Common Stock Shares Outstanding1.3 M910.1 K1.3 M
Very volatile
Liabilities And Stockholders Equity52.4 M73.6 M38.3 M
Slightly volatile
Capital Surpluse106.8 M101.7 M39.8 M
Slightly volatile
Other Current Assets862.3 K1.5 M650.4 K
Slightly volatile
Other Stockholder Equity104.9 M99.9 M38.2 M
Slightly volatile
Total Liabilities6.7 M11.1 M5.1 M
Slightly volatile
Total Current Assets37.9 M37.1 M26.8 M
Slightly volatile
Common Stock23.5 K34.1 K43.6 K
Slightly volatile
Property Plant Equipment3.1 M2.9 M1 M
Slightly volatile
Short and Long Term Debt Total2.2 M2.5 M1.4 M
Slightly volatile
Net Receivables144.8 K152.5 K2.3 M
Pretty Stable
Common Stock Total Equity21.9 K40 K20 K
Slightly volatile
Long Term Debt Total387.4 K400.5 K466.7 K
Slightly volatile
Non Current Liabilities Total2.8 M2.7 M2 M
Slightly volatile
Property Plant And Equipment Gross9.8 M9.4 M2.6 M
Slightly volatile
Short and Long Term Debt2 M2.2 M1.5 M
Slightly volatile
Short Term Debt1.5 M824.1 K1.9 M
Pretty Stable
Other Liabilities3.3 M5.3 M2.2 M
Slightly volatile
Current Deferred Revenue44.6 K47 K82.5 K
Slightly volatile
Inventory1.2 M1.2 M1.2 M
Slightly volatile
Deferred Long Term Liabilities3.6 M2.8 M2.6 M
Slightly volatile
Net Invested Capital63.6 M62.5 M36.2 M
Slightly volatile
Long Term Investments688 K840.7 K402.7 K
Slightly volatile
Capital Stock31.7 K43.6 K22.4 K
Slightly volatile
Non Current Liabilities Other461.1 K485.4 K743.8 K
Slightly volatile

Co Diagnostics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.7 M1.6 M466 K
Slightly volatile
Selling General Administrative19.5 M18.6 M6.9 M
Slightly volatile
Selling And Marketing Expenses4 M5.2 M2.9 M
Slightly volatile
Other Operating Expenses26.1 M50.6 M20.1 M
Slightly volatile
Research Development25.3 M24.1 M8 M
Slightly volatile
Total Operating Expenses51.9 M49.4 M19.3 M
Slightly volatile
Interest Income1.3 M1.3 M371.5 K
Slightly volatile
Reconciled Depreciation1.7 M1.6 M475.3 K
Slightly volatile
Non Recurring12.3 M13.8 M15.1 M
Slightly volatile

Co Diagnostics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow17.6 M17.2 M12.5 M
Slightly volatile
Depreciation1.7 M1.6 M466 K
Slightly volatile
Capital Expenditures541.2 K860.6 K403.6 K
Slightly volatile
End Period Cash Flow3.2 M3.4 M11 M
Slightly volatile
Change To Netincome25.4 M24.2 M7.6 M
Slightly volatile
Stock Based Compensation3.8 M6.3 M2.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.356.682.7 K
Slightly volatile
Days Sales Outstanding13.514.2192.9672
Slightly volatile
Average Payables2.3 M2.1 M714 K
Slightly volatile
Stock Based Compensation To Revenue1.521.635.4536
Pretty Stable
Capex To Depreciation0.590.621.4329
Very volatile
EV To Sales6.136.452.7 K
Slightly volatile
Inventory Turnover1.340.840.9331
Slightly volatile
Days Of Inventory On Hand4284515.4 K
Slightly volatile
Payables Turnover0.260.274.5947
Pretty Stable
Sales General And Administrative To Revenue4.514.7584.5912
Slightly volatile
Average Inventory1.1 M1.2 M714.7 K
Slightly volatile
Research And Ddevelopement To Revenue5.856.1647.5254
Slightly volatile
Capex To Revenue0.210.226.3103
Slightly volatile
Cash Per Share24.0226.4822.5972
Slightly volatile
Days Payables Outstanding1.3 K1.4 K3.8 K
Very volatile
Intangibles To Total Assets0.230.370.2732
Slightly volatile
Current Ratio5.83.975.7004
Slightly volatile
Receivables Turnover27.9126.588.8337
Slightly volatile
Capex Per Share0.450.670.4364
Slightly volatile
Average Receivables198.1 K208.6 K2.4 M
Slightly volatile
Revenue Per Share3.313.4813.9016
Slightly volatile
Interest Debt Per Share3.332.452.6737
Pretty Stable
Debt To Assets0.03670.03871.27
Slightly volatile
Graham Number252311298
Slightly volatile
Operating Cycle4424655.4 K
Slightly volatile
Days Of Payables Outstanding1.3 K1.4 K3.8 K
Very volatile
Ebt Per Ebit1.131.081.0352
Pretty Stable
Quick Ratio5.473.845.4053
Slightly volatile
Net Income Per E B T0.720.90.9461
Slightly volatile
Cash Ratio0.340.362.6548
Pretty Stable
Days Of Inventory Outstanding4284515.4 K
Slightly volatile
Days Of Sales Outstanding13.514.2192.9672
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.181.0193
Pretty Stable
Fixed Asset Turnover0.690.728.6008
Pretty Stable
Debt Ratio0.03670.03871.27
Slightly volatile
Price Sales Ratio6.356.682.7 K
Slightly volatile
Asset Turnover0.05230.05510.1449
Pretty Stable
Gross Profit Margin0.80.860.8362
Slightly volatile

Co Diagnostics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap57.4 M71.4 M76.6 M
Slightly volatile
Enterprise Value46.2 M51 M60.2 M
Pretty Stable

CODX Fundamental Market Drivers

Forward Price Earnings16
Cash And Short Term Investments29.7 M

CODX Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue47 K44.6 K
Total Revenue4.5 M4.3 M
Cost Of Revenue1.1 M1.1 M
Stock Based Compensation To Revenue 1.60  1.52 
Sales General And Administrative To Revenue 4.75  4.51 
Research And Ddevelopement To Revenue 6.16  5.85 
Capex To Revenue 0.22  0.21 
Revenue Per Share 3.48  3.31 
Ebit Per Revenue(9.21)(9.67)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY